N. N. Teng

2.8k total citations · 1 hit paper
37 papers, 2.1k citations indexed

About

N. N. Teng is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, N. N. Teng has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Immunology. Recurrent topics in N. N. Teng's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Ovarian cancer diagnosis and treatment (6 papers) and Glycosylation and Glycoproteins Research (5 papers). N. N. Teng is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Ovarian cancer diagnosis and treatment (6 papers) and Glycosylation and Glycoproteins Research (5 papers). N. N. Teng collaborates with scholars based in United States, United Kingdom and Malaysia. N. N. Teng's co-authors include Daniel S. Kapp, Hillard Kaplan, John K. Chan, Kathryn Osann, M. K. Cheung, Teri A. Longacre, Marcia M. Bieber, Michael Hendrickson, Chad A. Hamilton and Matthew A. Powell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

N. N. Teng

36 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

2006 482 citations Chad A. Hamilton, M. K. Cheung et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. N. Teng United States	21	589	560	537	497	384	37	2.1k
Inga Laursen Denmark	22	120 0.2×	342 0.6×	156 0.3×	561 1.1×	123 0.3×	48	1.4k
Kurt Stromberg United States	27	116 0.2×	992 1.8×	125 0.2×	463 0.9×	242 0.6×	57	2.2k
Madhuri Koti Canada	31	743 1.3×	1.0k 1.8×	1.1k 2.0×	1.6k 3.3×	103 0.3×	82	3.3k
Yutaka Suehiro Japan	36	113 0.2×	1.6k 2.9×	148 0.3×	628 1.3×	148 0.4×	144	3.5k
Toshiharu Yasugi Japan	34	1.0k 1.8×	1.1k 2.0×	1.1k 2.1×	594 1.2×	46 0.1×	96	3.5k
Amos Orlofsky United States	24	95 0.2×	842 1.5×	77 0.1×	1.1k 2.1×	53 0.1×	34	2.1k
Nathalie Jacobs Belgium	28	278 0.5×	667 1.2×	32 0.1×	875 1.8×	61 0.2×	59	2.4k
H Takamizawa Japan	17	119 0.2×	425 0.8×	238 0.4×	189 0.4×	54 0.1×	135	1.3k
Michelle Moore United States	23	56 0.1×	425 0.8×	57 0.1×	647 1.3×	172 0.4×	54	1.8k
Hilmar Berger Germany	25	48 0.1×	1.1k 2.1×	177 0.3×	372 0.7×	119 0.3×	50	2.7k

Countries citing papers authored by N. N. Teng

Since Specialization

Citations

This map shows the geographic impact of N. N. Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. N. Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. N. Teng more than expected).

Fields of papers citing papers by N. N. Teng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. N. Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. N. Teng. The network helps show where N. N. Teng may publish in the future.

Co-authorship network of co-authors of N. N. Teng

This figure shows the co-authorship network connecting the top 25 collaborators of N. N. Teng. A scholar is included among the top collaborators of N. N. Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. N. Teng. N. N. Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zakaria, Rozana, et al.. (2023). ORGANISATION OCCUPATIONAL SAFETY AND HEALTH PERFORMANCE ADAPTATION FOR LIBYA CONSTRUCTION COMPANY. 17(1). 178–194. 2 indexed citations

Ray, Jason C., et al.. (2017). Down Regulation of MAPK Signaling by Cytotoxic Human Monoclonal Antibody in Epithelial Ovarian Cancer. Gynecologic Oncology. 147(1). 220–220. 2 indexed citations

Liedtke, Michaela, Clare J. Twist, Bruno C. Medeiros, et al.. (2011). Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia. Haematologica. 97(1). 30–37. 21 indexed citations

Chan, John K., et al.. (2007). Safety and efficacy of lenalidomide (Revlimid®) in recurrent ovarian and primary peritoneal carcinoma. Gynecologic Oncology. 105(1). 194–198. 13 indexed citations

Chan, John K., Renata R. Urban, Jacob Y. Shin, et al.. (2007). The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13 918 patients. British Journal of Cancer. 96(12). 1817–1822. 84 indexed citations

Chan, John K., H. Henry Guo, M. K. Cheung, et al.. (2006). The role of surgical staging in grade 1 endometrioid corpus cancer. Journal of Clinical Oncology. 24(18_suppl). 5009–5009. 1 indexed citations

Hamilton, Chad A., M. K. Cheung, Kathryn Osann, et al.. (2006). Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. British Journal of Cancer. 94(5). 642–646. 482 indexed citations breakdown →

Chan, John K., Renata R. Urban, M. K. Cheung, et al.. (2006). Ovarian cancer in younger vs older women: a population-based analysis. British Journal of Cancer. 95(10). 1314–1320. 115 indexed citations

Anderson, Eric M., John Chan, Mobin Karimi, et al.. (2006). Bispecific Antibody-Redirected Immunotherapy of Her2/Neu-Expressing Uterine Cancer. Journal of Investigative Medicine. 54(1_suppl). 104–104. 2 indexed citations

10.

Kapp, Daniel S., et al.. (2000). Malignant granular cell tumor of the vulva in a 17-year-old: Case report and literature review. International Journal of Gynecological Cancer. 10(5). 429–434. 22 indexed citations

11.

Vollenhoven, Ronald van, Marcia M. Bieber, M.J. Powell, et al.. (1999). VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.. PubMed. 26(8). 1727–33. 99 indexed citations

12.

Bhat, Neelima M., Marcia M. Bieber, Frank J. Hsu, et al.. (1997). Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II. Clinical & Experimental Immunology. 108(1). 151–159. 27 indexed citations

13.

Bhat, Neelima M., Marcia M. Bieber, Caroline Chapman, Freda K. Stevenson, & N. N. Teng. (1993). Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells.. The Journal of Immunology. 151(9). 5011–5021. 71 indexed citations

14.

Teng, N. N., et al.. (1990). Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy. Gynecologic Oncology. 37(2). 292–295. 43 indexed citations

15.

McGuire, W. P., James C. Arseneau, John A. Blessing, et al.. (1989). A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.. Journal of Clinical Oncology. 7(10). 1462–1468. 110 indexed citations

16.

Kakudo, Kennichi, et al.. (1989). Deletion of Histo-blood Group A and B Antigens and Expression of Incompatible A Antigen in Ovarian Cancer. JNCI Journal of the National Cancer Institute. 81(15). 1151–1157. 28 indexed citations

17.

Keay, S., et al.. (1988). Topical Interferon for Treating Condyloma Acuminata in Women. The Journal of Infectious Diseases. 158(5). 934–939. 44 indexed citations

18.

Smith, Lloyd H., et al.. (1987). Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes. Journal of Immunological Methods. 105(2). 263–273. 7 indexed citations

19.

Feeley, Thomas W., et al.. (1987). Cardiovascular effect of intravenous lipid A in rabbits.. PubMed. 23(4). 285–93. 3 indexed citations

20.

Bron, Dominique, Mark B. Feinberg, N. N. Teng, & Hillard Kaplan. (1984). Production of human monoclonal IgG antibodies against Rhesus (D) antigen.. Proceedings of the National Academy of Sciences. 81(10). 3214–3217. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact